Biomarkers to assess disease progression are in use, but none can predict which therapy will work best for each patient
Search results for: inhibitor
2014 ACR/ARHP Annual Meeting: Lung Fibrosis
New drugs, targeted treatments for idiopathic pulmonary fibrosis
New Compound Promotes Recovery from Spinal Cord Injury
Research suggests delivery of protein peptide can restore serotonergic innervation to spinal cord below level of injury; facilitate recovery of locomotor and urinary system function
The ACR/ARHP Member News
Awards, appointments and announcements in the world of rheumatology
2014 ACR/ARHP Annual Meeting: Fat’s Role in Inflammation
How obesity, metabolic stress, inflammation contribute to rheumatic diseases
Osteoimmunology Research May Benefit Patients with Rheumatoid Arthritis
Cross-talk between bone biology, immune system may shed light on joint erosion, refine therapeutic targets for RA
Biomarkers to Guide Diagnosis, Treatment of Rheumatic Diseases
Examining the usefulness, drawbacks of current biomarkers in rheumatology and progress to develop better ones
Hydrocodone Bitartrate, Secukinumab, Varenicline Updates, Trials, Approvals
Plus, rheumatology drug news, safety updates
10 Tips for Opioid Prescribing
How to manage the risks when prescribing medications for patients in chronic pain
Cure, Effective Treatment for Lupus Nephritis Remain Elusive Despite Advances
Rheumatology experts review history of LN, offer explanations for roadblocks to better therapies
- « Previous Page
- 1
- …
- 87
- 88
- 89
- 90
- 91
- …
- 110
- Next Page »